Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trial

Autor: Giladi, Nir, Alcalay, Roy N, Cutter, Gary, Gasser, Thomas, Gurevich, Tanya, Höglinger, Günter U, Marek, Kenneth, Pacchetti, Claudio, Schapira, Anthony H V, Scherzer, Clemens R, Simuni, Tanya, Minini, Pascal, Sardi, S Pablo, Peterschmitt, M Judith *
Zdroj: In The Lancet Neurology August 2023 22(8):661-671
Databáze: ScienceDirect